Literature DB >> 764920

Immunological features in multiple sclerosis.

G Lamoureux, N Giard, R Jolicoeur, V Toughlian, M Desrosiers.   

Abstract

A clinical and laboratory profile of the immunological system of patients with multiple sclerosis (MS) strongly suggested that many specific immune deficiencies exist in MS. The immunological history showed that patients with MS had had more tonsillectomies, appendicectomies, and childhood infections than matched controls, which suggested that there had been problems in controlling various types of childhood infections. The cell-mediated immune response and the circulating antibody titres were specifically impaired against a variety of antigens. Patients with MS had significantly lower serum antibody titres than controls against many naturally occurring antigens-namely, diptheria and tetanus toxoids, adenovirus, and mumps viruses. Raised serum antibody titres were found against measles and varicella zoster viruses while no difference was found towards other antigens. The delayed hypersensitivity reaction and the immunological memory of patients with MS were also greatly reduced against the mumps skin test antigens. There were normal amounts of circulating T and B lymphocytes, and the phytohaemagglutinin, concanavallin A, pokeweed mitogen, and encephalitogens lymphocyte transformation was not different from that in controls. These results indicated that patients with MS have more infectious problems than normal people and that both their T and B cell systems cannot mount a fully normal immunological response to some viral and bacterial antigens, while they give an increased response to others.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 764920      PMCID: PMC1638425          DOI: 10.1136/bmj.1.6003.183

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  15 in total

1.  Measles antibodies in multiple sclerosis.

Authors:  J M ADAMS; D T IMAGAWA
Journal:  Proc Soc Exp Biol Med       Date:  1962-12

2.  AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS.

Authors:  E A Kabat; D H Moore; H Landow
Journal:  J Clin Invest       Date:  1942-09       Impact factor: 14.808

3.  Immune studies in multiple sclerosis.

Authors:  G Lamoureux; A G Borduas
Journal:  Clin Exp Immunol       Date:  1966-10       Impact factor: 4.330

4.  Histocompatibility-linked immune-response determinants in multiple sclerosis.

Authors:  C Jersild; B Dupont; T Fog; G S Hansen; L S Nielsen; M Thomsen; A Svejgaard
Journal:  Transplant Proc       Date:  1973-12       Impact factor: 1.066

5.  HL-A antigens and multiple sclerosis.

Authors:  C Jersild; A Svejgaard; T Fog
Journal:  Lancet       Date:  1972-06-03       Impact factor: 79.321

6.  Prior events in multiple sclerosis.

Authors:  R D Currier; E A Martin; P C Woosley
Journal:  Neurology       Date:  1974-08       Impact factor: 9.910

7.  [Induction of experimental allergic encephalitis with synthetic human encephalitogenic substances].

Authors:  G Lamoureux; G Thibeault; G Richer; C Bernard
Journal:  Union Med Can       Date:  1972-04

8.  Cerebrospinal fluid proteins in multiple sclerosis.

Authors:  G Lamoureux; R Jolicoeur; N Giard; M St-Hilaire; F Duplantis
Journal:  Neurology       Date:  1975-06       Impact factor: 9.910

9.  A suppression of cellular immunity in patients with multiple sclerosis.

Authors:  V Utermohlen; J B Zabriskie
Journal:  J Exp Med       Date:  1973-12-01       Impact factor: 14.307

10.  Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells.

Authors:  M Jondal; G Holm; H Wigzell
Journal:  J Exp Med       Date:  1972-08-01       Impact factor: 14.307

View more
  10 in total

1.  A 'profile' of immune responsiveness in multiple sclerosis.

Authors:  G R Symington; I R Mackay; S Whittingham; J White; J D Buckley
Journal:  Clin Exp Immunol       Date:  1978-02       Impact factor: 4.330

2.  A clinical and immunological study of the effects of transfer factor on multiple sclerosis patients.

Authors:  G Lamoureux; J Cosgrove; P Duquette; Y Lapierre; R Jolicoeur; F Vanderland
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

3.  Spontaneous and mutagen induced sister chromatid exchange in multiple sclerosis.

Authors:  M S Newton; C M Steel; H J Evans; B Pentland
Journal:  J Med Genet       Date:  1983-10       Impact factor: 6.318

4.  HLA antigens-linked genetic control in multiple sclerosis patients resistant and susceptible to infection.

Authors:  G Lamoureux; P Duquette; Y Lapierre; B Cosgrove; G Bourret; L Labrie
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

5.  Past infectious events and disease evolution in multiple sclerosis.

Authors:  G Lamoureux; Y Lapierre; G Ducharme
Journal:  J Neurol       Date:  1983       Impact factor: 4.849

6.  Serum titers of IgG antibodies against tetanus and diphtheria toxoids and risk of multiple sclerosis.

Authors:  J Massa; K L Munger; E J O'Reilly; L I Levin; A Ascherio
Journal:  J Neuroimmunol       Date:  2009-02-07       Impact factor: 3.478

7.  T lymphocyte populations in multiple sclerosis.

Authors:  U Rodeck; E Kuwert; H W Scharafinski; H J Lehmann
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1985

8.  Measles virus infection and multiple sclerosis: serological studies.

Authors:  W Cendrowski; I Polna; K Nowicka
Journal:  J Neurol       Date:  1976-10-04       Impact factor: 4.849

9.  Tests on peripheral blood cells in multiple sclerosis.

Authors:  S McCrea; M Killen; J Thompson; W A Fleming; T A McNeill; J H Millar
Journal:  Ulster Med J       Date:  1979

Review 10.  Surgery and risk for multiple sclerosis: a systematic review and meta-analysis of case-control studies.

Authors:  Carole Lunny; Jennifer A Knopp-Sihota; Shawn N Fraser
Journal:  BMC Neurol       Date:  2013-05-06       Impact factor: 2.474

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.